196 related articles for article (PubMed ID: 24307202)
1. Bronchoprotection by olodaterol is synergistically enhanced by tiotropium in a guinea pig model of allergic asthma.
Smit M; Zuidhof AB; Bos SI; Maarsingh H; Gosens R; Zaagsma J; Meurs H
J Pharmacol Exp Ther; 2014 Feb; 348(2):303-10. PubMed ID: 24307202
[TBL] [Abstract][Full Text] [Related]
2. Tiotropium sustains the anti-inflammatory action of olodaterol via the cyclic AMP pathway.
Costa L; Roth M; Miglino N; Keglowich L; Zhong J; Lardinois D; Tamm M; Borger P
Pulm Pharmacol Ther; 2014 Feb; 27(1):29-37. PubMed ID: 24269928
[TBL] [Abstract][Full Text] [Related]
3. Positive interaction of the novel beta2-agonist carmoterol and tiotropium bromide in the control of airway changes induced by different challenges in guinea-pigs.
Rossoni G; Manfredi B; Razzetti R; Civelli M; Berti F
Pulm Pharmacol Ther; 2007; 20(3):250-7. PubMed ID: 16533614
[TBL] [Abstract][Full Text] [Related]
4. The effect of tiotropium in combination with olodaterol on house dust mite-induced allergic airway disease.
John-Schuster G; de Kleijn S; van Wijck Y; Kremer V; Smits HH; Pieper MP; Hiemstra PS; Taube C
Pulm Pharmacol Ther; 2017 Aug; 45():210-217. PubMed ID: 28687462
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi.
Calzetta L; Rogliani P; Mattei M; Alfonsi P; Cito G; Pistocchini E; Cazzola M; Matera MG
COPD; 2017 Oct; 14(5):526-532. PubMed ID: 28745522
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling.
Gosens R; Bos IS; Zaagsma J; Meurs H
Am J Respir Crit Care Med; 2005 May; 171(10):1096-102. PubMed ID: 15695490
[TBL] [Abstract][Full Text] [Related]
7. Early protective effects of tiotropium bromide in patients with airways hyperresponsiveness.
Terzano C; Petroianni A; Ricci A; D'Antoni L; Allegra L
Eur Rev Med Pharmacol Sci; 2004; 8(6):259-64. PubMed ID: 15745385
[TBL] [Abstract][Full Text] [Related]
8. The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease.
Beeh KM; Westerman J; Kirsten AM; Hébert J; Grönke L; Hamilton A; Tetzlaff K; Derom E
Pulm Pharmacol Ther; 2015 Jun; 32():53-9. PubMed ID: 25956072
[TBL] [Abstract][Full Text] [Related]
9. β₂ long-acting and anticholinergic drugs control TGF-β1-mediated neutrophilic inflammation in COPD.
Profita M; Bonanno A; Montalbano AM; Albano GD; Riccobono L; Siena L; Ferraro M; Casarosa P; Pieper MP; Gjomarkaj M
Biochim Biophys Acta; 2012 Jul; 1822(7):1079-89. PubMed ID: 22440430
[TBL] [Abstract][Full Text] [Related]
10. Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.
Sauer R; Hänsel M; Buhl R; Rubin RA; Frey M; Glaab T
Int J Chron Obstruct Pulmon Dis; 2016; 11():891-8. PubMed ID: 27217742
[TBL] [Abstract][Full Text] [Related]
11. Bronchoprotection in conscious guinea pigs by budesonide and the NO-donating analogue, TPI 1020, alone and combined with tiotropium or formoterol.
Turner Dl; Ferrari N; Ford WR; Kidd EJ; Nevin B; Paquet L; Renzi P; Broadley KJ
Br J Pharmacol; 2012 Oct; 167(3):515-26. PubMed ID: 22563753
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of the interaction between tiotropium bromide and olodaterol on human bronchi and small airways.
Calzetta L; Rogliani P; Page C; Rinaldi B; Cazzola M; Matera MG
Pulm Pharmacol Ther; 2019 Jun; 56():39-50. PubMed ID: 30876907
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of inhaled tiotropium in asthma, uncontrolled with standard combination therapy.
Antoniu SA; Antohe I
Expert Opin Pharmacother; 2013 May; 14(7):967-9. PubMed ID: 23514606
[TBL] [Abstract][Full Text] [Related]
14. Application of the classical Einthoven model of bronchoconstriction to the study of inhaled bronchodilators in rodents.
McNamara A; Pulido-Rios MT; Hegde SS; Martin WJ
J Pharmacol Toxicol Methods; 2011; 63(1):89-95. PubMed ID: 20594937
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of olodaterol, a novel inhaled beta2-adrenoceptor agonist exerting a 24-hour-long duration of action in preclinical models.
Bouyssou T; Casarosa P; Naline E; Pestel S; Konetzki I; Devillier P; Schnapp A
J Pharmacol Exp Ther; 2010 Jul; 334(1):53-62. PubMed ID: 20371707
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy of tiotropium and ciclesonide attenuates airway inflammation and remodeling in a guinea pig model of chronic asthma.
Kistemaker LE; Bos IS; Menzen MH; Maarsingh H; Meurs H; Gosens R
Respir Res; 2016 Feb; 17():13. PubMed ID: 26846267
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium-olodaterol for patients with COPD in the Netherlands.
van Boven JF; Kocks JW; Postma MJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2191-2201. PubMed ID: 27703341
[TBL] [Abstract][Full Text] [Related]
18. Inhalation of the Rho-kinase inhibitor Y-27632 reverses allergen-induced airway hyperresponsiveness after the early and late asthmatic reaction.
Schaafsma D; Bos IS; Zuidhof AB; Zaagsma J; Meurs H
Respir Res; 2006 Sep; 7(1):121. PubMed ID: 17002806
[TBL] [Abstract][Full Text] [Related]
19. The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs.
van den Berg MPM; Nijboer-Brinksma S; Bos IST; van den Berge M; Lamb D; van Faassen M; Kema IP; Gosens R; Kistemaker LEM
Respir Res; 2021 Feb; 22(1):48. PubMed ID: 33557843
[TBL] [Abstract][Full Text] [Related]
20. Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
Vogelmeier C; Hederer B; Glaab T; Schmidt H; Rutten-van Mölken MP; Beeh KM; Rabe KF; Fabbri LM;
N Engl J Med; 2011 Mar; 364(12):1093-1103. PubMed ID: 21428765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
